UnitedHealth Group Reports $447.6 Billion Revenue, Net Earnings Decline by 16% in 2025

UnitedHealth Group Incorporated reported a consolidated revenue of $447.6 billion for the fiscal year ending December 31, 2025, marking a 12% increase from $400.3 billion in 2024. The company's profitability, however, faced challenges, with net earnings attributable to common shareholders declining by 16% to $12.1 billion, or $13.23 per diluted share, compared to $14.4 billion, or $15.51 per diluted share, in the previous year. This decrease in earnings was primarily attributed to elevated medical costs, restructuring actions, and the impacts of a cyberattack on its Change Healthcare business.

In terms of operational metrics, UnitedHealthcare served approximately 49.8 million individuals as of December 31, 2025, an increase of 415,000 from the previous year. The growth was driven by an increase in fee-based commercial offerings and Medicare Advantage, although there was a decline in risk-based commercial offerings. The company’s medical care ratio rose to 89.1%, up from 85.5% in 2024, reflecting the rising medical costs associated with its services. Additionally, the company reported a total medical cost of $314 billion, a 19% increase from the prior year, largely due to the impacts of the Inflation Reduction Act on Medicare Part D plans and increased care activity.

Strategically, UnitedHealth Group undertook significant restructuring actions in 2025, resulting in a total impact of $2.5 billion, which included workforce reductions and the establishment of loss contract reserves. The company also recorded a net gain of $568 million from portfolio divestitures, including a notable gain of $1.5 billion from Optum Rx, which was partially offset by losses in other segments. Furthermore, the company announced a realignment of its business segments effective January 1, 2026, moving Optum Financial, including Optum Bank, from Optum Health to Optum Insight to better respond to market changes.

Looking ahead, UnitedHealth Group anticipates continued growth in the health care market, driven by demographic trends and advancements in medical technology. However, the company also faces challenges, including ongoing pressures on Medicare Advantage funding and the need to manage rising medical costs effectively. The company expects to see a contraction in its Medicare Advantage membership in 2026 due to these funding pressures and anticipates further adjustments in its pricing and benefit design strategies to align with market conditions. Overall, while UnitedHealth Group's revenue growth remains strong, its profitability and operational metrics indicate a need for careful management of costs and strategic adjustments in response to evolving market dynamics.